Masashi Fujimoto, Tomoyasu Sano, Yuta Sano, Satoshi Inoue, Kazuna Matsuo, Tomokazu Kimura et al. Recurrent TFE3‐Rearranged Renal Cell Carcinoma Responding to Pembrolizumab Plus Lenvatinib After Postoperative Pembrolizumab: A Case Report. // IJU Case Reports. – 2026. – DOI: 10.1002/iju5.70280. – URL: https://onlinelibrary.wiley.com/doi/10.1002/iju5.70280?af=R
Masashi Fujimoto, Tomoyasu Sano, Yuta Sano, Satoshi Inoue, Kazuna Matsuo, Tomokazu Kimura, Shohei Ishida, Kenji Zennami, Yoshihisa Matsukawa, & Shusuke Akamatsu (2026). Recurrent TFE3‐Rearranged Renal Cell Carcinoma Responding to Pembrolizumab Plus Lenvatinib After Postoperative Pembrolizumab: A Case Report. IJU Case Reports. https://doi.org/10.1002/iju5.70280
Masashi Fujimoto, et al. “Recurrent TFE3‐Rearranged Renal Cell Carcinoma Responding to Pembrolizumab Plus Lenvatinib After Postoperative Pembrolizumab: A Case Report.” IJU Case Reports, 2026. doi:10.1002/iju5.70280.
@article{Fujimoto2026,
title = {Recurrent TFE3‐Rearranged Renal Cell Carcinoma Responding to Pembrolizumab Plus Lenvatinib After Postoperative Pembrolizumab: A Case Report},
author = {Fujimoto, Masashi and Sano, Tomoyasu and Sano, Yuta and Inoue, Satoshi and Matsuo, Kazuna and Kimura, Tomokazu and Ishida, Shohei and Zennami, Kenji and Matsukawa, Yoshihisa and Akamatsu, Shusuke},
journal = {IJU Case Reports},
year = {2026},
doi = {10.1002/iju5.70280},
url = {https://onlinelibrary.wiley.com/doi/10.1002/iju5.70280?af=R}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...